XML 20 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Revenue:      
Product revenue, net $ 112,527 $ 55,720 $ 45,238
License, collaboration and other revenue 6,277 49,692 323
Total revenue 118,804 105,412 45,561
Operating expenses:      
Cost of product revenue 2,114 5,224 9,612
Research and development expense 171,216 120,593 162,900
Selling, general and administrative expense 162,750 139,790 146,615
Total operating expenses 336,080 265,607 319,127
Loss from operations (217,276) (160,195) (273,566)
Other income (expense):      
Interest income 82 85 130
Interest expense (18,149) (8,075) (153)
Gain on disposition of stock   4,768  
Foreign exchange gain (loss) 793 1,445 (130)
Other expense, net (17,274) (1,777) (153)
Loss before provision for income taxes (234,550) (161,972) (273,719)
Benefit from (provision for) income taxes 3,394 (630) (439)
Net loss $ (231,156) $ (162,602) $ (274,158)
Net loss per share - basic and diluted $ (1.23) $ (0.87) $ (1.49)
Weighted-average number of shares of common stock outstanding - basic and diluted 188,669 186,835 183,575